Comparison of seven CD19 CAR designs in engineering NK cells for enhancing anti-tumour activity.
Wang Y, Li J, Wang Z, Liu Y, Wang T, Zhang M, Xia C, Zhang F, Huang D, Zhang L, Zhao Y, Liu L, Zhu Y, Qi H, Zhu X, Qian W, Hu F, Wang J.
Wang Y, et al. Among authors: huang d.
Cell Prolif. 2024 Jun 3:e13683. doi: 10.1111/cpr.13683. Online ahead of print.
Cell Prolif. 2024.
PMID: 38830795